Generex Biotechnology Corporation (GNBT) Stock Analysis
DELISTED
What happened to Generex Biotechnology Corporation (GNBT) stock?
Generex Biotechnology Corporation (GNBT) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Generex Biotechnology Corporation (GNBT). GenBioTech, Inc. is a biotechnology company focused on developing and commercializing innovative therapies for cancer treatment. The company's lead drug candidate, CLL-I, is designed to target and eliminate cancer cells while minimizing harm to healthy cells.
Last analyzed: Mar 18, 2026Generex Biotechnology Corporation (GNBT) Healthcare & Pipeline Overview
GNBT OTC Market Information
GNBT trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy GNBT shares?
No. GNBT stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for GNBT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GNBT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Generex Biotechnology Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.